You're reading: The Globe and Mail: Canada begins clinical trial of experimental COVID-19 treatment using plasma from recovered individuals

The Globe and Mail: Canada begins clinical trial of experimental COVID-19 treatment using plasma from recovered individuals

By The Globe and Mail.

Published April 7, 2020 at 8:38 am

A laboratory technician analyses samples looking into patients' DNA to see whether they are infected with COVID-19 in the Institute of Molecular Biology and Genetics in Kyiv on April 2, 2020.

Photo by Oleg Petrasiuk

A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19. The study, which will involve 1,000 patients from across the country, will include at least 40 Canadian hospitals, and is being overseen by doctors from the University of Montreal, University of Ottawa, University of Toronto, McMaster and the University of British Columbia, among other schools.